STRATEC Biomedical AG
Aperta
17.48 3.43
Panoramica
Variazione del prezzo dell'azione
24h
Minimo
16.68
Massimo
17.74
Entrata | 2.6M -1.7M |
|---|---|
Vendite | -22M 53M |
P/E Media del settore | 14.63 30.136 |
EPS | -0.357 |
Rendimento da dividendi | 3.3 |
Margine di Profitto | -3.206 |
Dipendenti | 1,395 |
EBITDA | -6.7M 4.1M |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +55.9% upside |
Rendimento da dividendi Media del settore | 3.30% 3.27% |
|---|---|
Utili prossimi | 14 ago 2026 |
Capitalizzazione di Mercato | 6.8M 221M |
|---|---|
Apertura precedente | 14.05 |
Chiusura precedente | 17.48 |
STRATEC Biomedical AG Grafico
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
Chi Siamo STRATEC Biomedical AG
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
